GlaxoSmithKline (GSK) has developed a version of its Sensodyne ProNamel toothpaste specifically for children, according to the company. ProNamel for Children offers the same enamel strengthening ...

Following the demerger and premium listing of Haleon in July 2022, GSK initially retained a 12.94% stake in Haleon. As a result of the disposals, GSK has sold 1.19 billion shares in Haleon for ...

The share sale and buyback are expected to reduce Pfizer's interest in Haleon from 32% to approximately 24%. In its fourth-quarter release, Haleon added that it expects to allocate £500 million to buy ...

WARREN, N.J., Sept. 28, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) is raising a cup – or two – of coffee to celebrate enjoying life's simple pleasures without the interruption of ...

(Reuters) -Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32% stake in Haleon, said ...

(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner JPMorgan ...

GlaxoSmithKline (GSK) and Dentsply have entered into an agreement to create a portfolio of co-branded oral care products to be used in the dental office by patients suffering from tooth sensitivity.

Jan 17 (Reuters) - GSK (GSK.L), opens new tab has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon (HLN.L), opens new tab ...

US drugs giant Pfizer has sold a stake in Sensodyne and Panadol maker Haleon worth around £2.4 billion, cutting its holding from 22% to 15%. Pfizer sold 640 million shares in Haleon for 380p each, ...

Oct 5 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Thursday it intends to sell a 2.9% stake, or about 270 million shares, in its spun-off consumer healthcare business Haleon (HLN.L ...

Jan 16 (Reuters) - GSK GSK.L will sell a 3.2% stake, or about 300 million shares, in its spun-off consumer healthcare business Haleon HLN.L, the British drugmaker said on Tuesday. The announcement ...